Skip to main content
Rheumatology (Oxford, England) logoLink to Rheumatology (Oxford, England)
. 2022 Apr 1;61(10):4219. doi: 10.1093/rheumatology/keac168

Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients

Nathalie Luurssen-Masurel 1,, Elise Van Mulligen 2, Angelique Elisabeth Adriana Maria Weel 3,4,5, Johanna Maria Wilhelmina Hazes 6, Pascal Hendrik Pieter de Jong 7, the tREACH group investigators
PMCID: PMC9536788  PMID: 35362536

Rheumatology 2021;60:5765–5774. https://doi.org/10.1093/rheumatology/keab251

In the originally published article, the names of the authors were transposed. These should read “Nathalie Luurssen-Masurel, Elise van Mulligen, Angelique Elisabeth Adriana Maria Weel, Johanna Maria Wilhelmina Hazes, Pascal Hendrik Pieter de Jong” instead of: “Luurssen-Masurel Nathalie, Van Elise Mulligen, Weel Angelique Elisabeth Adriana Maria, Hazes Johanna Maria Wilhelmina, de Jong Pascal Hendrik Pieter”. These errors have now been corrected online.

Contributor Information

Nathalie Luurssen-Masurel, Department of Rheumatology, Erasmus Medical Center.

Elise Van Mulligen, Department of Rheumatology, Erasmus Medical Center.

Angelique Elisabeth Adriana Maria Weel, Department of Rheumatology, Erasmus Medical Center; Department of Rheumatology, Maasstad Hospital; Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands.

Johanna Maria Wilhelmina Hazes, Department of Rheumatology, Erasmus Medical Center.

Pascal Hendrik Pieter de Jong, Department of Rheumatology, Erasmus Medical Center.


Articles from Rheumatology (Oxford, England) are provided here courtesy of Oxford University Press

RESOURCES